Clinical trial
Transcranial Electrical Stimulation Modalities for the Treatment of Clinical Symptoms and Cognitive Deficits in Attention-deficit Hyperactivity Disorder Disorder
NCT06974136 is registered in ClinicalTrials.gov with The National Brain Mapping Laboratory (NBML) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcranial Electrical Stimulation Modalities for the Treatment of Clinical Symptoms and Cognitive Deficits in Attention-deficit Hyperactivity Disorder Disorder
- Lead sponsor
- The National Brain Mapping Laboratory (NBML)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 30, 2025
- Completion date
- May 1, 2026
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.